Konica Minolta Healthcare Americas, Inc. and HydroCision Inc. recently signed a distribution agreement to make the TenJet System available to U.S. patients for minimally invasive tendinopathy treatment.
New Agreement Makes TenJet System Available to U.S. Patients
1 min read Premium comments
Secondary#konicaminoltahealthcareamericas#tendinopathy#hydrocision
According to a press release, the Tenjet Percutaneous Tenotomy System is “an all-in-one tool for needling, debridement and lavage of diseased tendon tissue under ultrasound guidance.”
Unlike other technologies available today, TenJet is able to deliver a non-thermal stream of saline which reduces the risk of damage to the surrounding healthy tissue.
“This agreement with HydroCision further demonstrates Konica Minolta Healthcare’s commitment to advancing [musculoskeletal] ultrasound and related procedures, said Brian Noyes, senior vice president and general manager of ultrasound, Konica Minolta Healthcare Americas, Inc., in the release.
“We have seen an increase in the number of physicians who want to perform ultrasound-guided procedures. The TenJet system is a perfect solution for many patients who suffer from chronic tendon pain. By combining HydroCision’s Tenjet technology with our SONIMAGW HS1 and J5 ultrasound systems, we will be able to provide physicians with a total solution for patient treatments.”
“We are excited about our US distribution partnership with Konica Minolta Healthcare,” Paul Kowalski, president and CEO, HydroCision, Inc., said in the release.
“Ultrasound is ideal for the diagnosis, procedural guidance and postoperative care of patients who suffer from chronic tendinopathy who have not responded to conservative treatment. Konica Minolta Healthcare’s strategic interest in ultrasound-guided minimally invasive procedures, combined with its direct sales presence and physician training capabilities, bodes well for a successful partnership. We look forward to working collaboratively to establish the TenJet procedure as a standard of care in the field of tendinopathy treatment,” he added.
Konica Minolta Healthcare Americas, Inc., headquartered in Wayne, New Jersey, is a leader in medical diagnostic imaging and healthcare information technology. HydroCision, Inc., headquartered in Billerica, Massachusetts, is a medical device company specializing in their proprietary fluidjet technology for minimally invasive soft tissue removal.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.